Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amplia Therapeutics ( (AU:ATX) ) has shared an announcement.
Amplia Therapeutics Limited announced a proposed issue of securities, including a securities purchase plan and a placement, with a total of 107,673,920 ordinary fully paid securities to be issued. This move is aimed at raising capital to support the company’s ongoing projects and strategic initiatives, potentially enhancing its market position and providing opportunities for growth.
More about Amplia Therapeutics
Amplia Therapeutics Limited operates in the biotechnology industry, focusing on the development of therapeutic products. The company is primarily engaged in advancing treatments for diseases with significant unmet medical needs.
Average Trading Volume: 6,618,883
Technical Sentiment Signal: Buy
Current Market Cap: A$110.8M
See more data about ATX stock on TipRanks’ Stock Analysis page.